| Filed On | Filing |
|---|---|
| 12 Nov 2026 | 8-K/A: Entry into a Material Definitive Agreement; Other Events |
| 27 Mar 2025 |
8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure
MALVERN, PA., March 27, 2025 – Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) is issuing this press release to update the reporting of its financial results for the fourth quarter and full year ending December 31, 2024... |
| 06 Feb 2025 |
8-K/A: Financial Statements and Exhibits
See accompanying notes to condensed interim consolidated financial statements. |
| 13 Nov 2024 |
8-K/A: Results of Operations and Financial Condition
MALVERN, PA., November 12, 2024 – In a release issued earlier today under the same headline by Neuronetics, Inc. (NASDAQ: STIM), please note that in the second paragraph of the “Stockholders Approve Acquisition of Greenbrook TMS,” it sho... |
| 20 Oct 2021 |
8-K/A: Results of Operations and Financial Condition
CORRECTION - Neuronetics Announces Preliminary Revenue for Third Quarter 2021 |
| 03 Aug 2021 |
8-K/A: Results of Operations and Financial Condition
MALVERN, PA., August 3, 2021– Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatr... |
Loading...